These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11883091)

  • 1. Large-scale production of retroviral vectors for systemic gene delivery.
    Huentelman MJ; Reaves PY; Katovich MJ; Raizada MK
    Methods Enzymol; 2002; 346():562-73. PubMed ID: 11883091
    [No Abstract]   [Full Text] [Related]  

  • 2. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
    Blesch A
    Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient gene transduction into the brain using high-titer retroviral vectors.
    Nanmoku K; Kawano M; Iwasaki Y; Ikenaka K
    Dev Neurosci; 2003; 25(2-4):152-61. PubMed ID: 12966213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo infection of mice by replication-competent MLV-based retroviral vectors.
    Bachrach E; Duch M; Pelegrin M; Dreja H; Pedersen FS; Piechaczyk M
    Methods Mol Med; 2003; 76():343-52. PubMed ID: 12526173
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions.
    Kasahara N; Dozy AM; Kan YW
    Science; 1994 Nov; 266(5189):1373-6. PubMed ID: 7973726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates.
    Onafuwa A; An W; Robson ND; Telesnitsky A
    J Virol; 2003 Apr; 77(8):4577-87. PubMed ID: 12663764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes.
    Cavazza A; Cocchiarella F; Bartholomae C; Schmidt M; Pincelli C; Larcher F; Mavilio F
    Gene Ther; 2013 Sep; 20(9):949-57. PubMed ID: 23615186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient production of retroviral- and lentiviral-based vectors for the transduction of Mammalian cells.
    Tonini T; Claudio PP; Giordano A; Romano G
    Methods Mol Biol; 2004; 285():141-8. PubMed ID: 15269408
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification and Injection of Retroviral Vectors.
    Tashiro A; Zhao C; Suh H; Gage FH
    Cold Spring Harb Protoc; 2015 Oct; 2015(10):925-31. PubMed ID: 26430255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping.
    Somia NV; Miyoshi H; Schmitt MJ; Verma IM
    J Virol; 2000 May; 74(9):4420-4. PubMed ID: 10756057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus.
    Kinsella TM; Nolan GP
    Hum Gene Ther; 1996 Aug; 7(12):1405-13. PubMed ID: 8844199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of hypertension by systemic delivery of retroviral vector containing type I angiotensin II receptor antisense cDNA.
    Reaves PY; Wang HW; Katovich MJ; Gelband CH; Raizada MK
    Methods; 2000 Nov; 22(3):211-8. PubMed ID: 11071816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease.
    Costa GL; Benson JM; Seroogy CM; Achacoso P; Fathman CG; Nolan GP
    J Immunol; 2000 Apr; 164(7):3581-90. PubMed ID: 10725713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of retroviral vectors with enhanced efficiency of transgene expression.
    Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
    J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays (February 17, 1993).
    Anderson WF; McGarrity GJ; Moen RC
    Hum Gene Ther; 1993 Jun; 4(3):311-21. PubMed ID: 8338878
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1.
    Matano T; Odawara T; Iwamoto A; Yoshikura H
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3165-9. PubMed ID: 8847525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors.
    Li M; Hantzopoulos PA; Banerjee D; Zhao SC; Schweitzer BI; Gilboa E; Bertino JR
    Hum Gene Ther; 1992 Aug; 3(4):381-90. PubMed ID: 1525211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral vectors for high-level transgene expression in T lymphocytes.
    Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
    Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transient three-plasmid expression system for the production of hepatocytes targeting retroviral vectors.
    Qi P; Han J; Lu Y; Wang C; Zhu B
    Acta Biochim Biophys Sin (Shanghai); 2007 Aug; 39(8):567-74. PubMed ID: 17687491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.